摘要
Aims: To evaluate the prognostic predictive values of cytochrome c, cytokines, and other laboratory measurements inserum collected during neurological onset in acute encephalopathy with multiple organ failure. Methods: In addition to general laboratory examinations, the concentrations of cytochrome c (apoptosis marker) and cytokines (inflammatory markers) were measured in serum samples collected at the initial phase in 29 patients with acute encephalopathy. The obtained values were evaluated as predictors for the development of severe encephalopathy. Results: Cytochrome c, tumour necrosis factor α(TNF-α), interleukin 6 (IL-6), soluble TNF-receptor1 (sTNF-R1), and aspartate aminotransferase (AST) concentrations at the initial phase were high and correlated well with patient outcome. High concentrations of serum cytochromec (>45 ng/ml), sTNF-R1 (>2000 pg/ml), AST (>58 IU/dl),IL-6 (>60 pg/ml), and TNF-α(>15 pg/ml) predicted an unfavourable prognosis (sequelae and death) at 93%, 79%, 82%,77%, and 60%, respectively. The specificity of those markers was 100%, 89%, 83%, 100%, and 100%, respectively. Conclusions:Serum cytochrome c is the most sensitive and specific predictor for the development of severe encephalopathy at the initial phase. Results suggest that this marker might be used to guide decisions regarding the start of the initial treatment and further intensive care.
Aims: To evaluate the prognostic predictive values of cytochrome c, cytokines, and other laboratory measurements inserum collected during neurological onset in acute encephalopathy with multiple organ failure. Methods: In addition to general laboratory examinations, the concentrations of cytochrome c (apoptosis marker) and cytokines (inflammatory markers) were measured in serum samples collected at the initial phase in 29 patients with acute encephalopathy. The obtained values were evaluated as predictors for the development of severe encephalopathy. Results: Cytochrome c, tumour necrosis factor α(TNF-α), interleukin 6 (IL-6), soluble TNF-receptor1 (sTNF-R1), and aspartate aminotransferase (AST) concentrations at the initial phase were high and correlated well with patient outcome. High concentrations of serum cytochromec (>45 ng/ml), sTNF-R1 (>2000 pg/ml), AST (>58 IU/dl),IL-6 (>60 pg/ml), and TNF-α(>15 pg/ml) predicted an unfavourable prognosis (sequelae and death) at 93%, 79%, 82%,77%, and 60%, respectively. The specificity of those markers was 100%, 89%, 83%, 100%, and 100%, respectively. Conclusions:Serum cytochrome c is the most sensitive and specific predictor for the development of severe encephalopathy at the initial phase. Results suggest that this marker might be used to guide decisions regarding the start of the initial treatment and further intensive care.
